Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. Biomedical Drug Synthesis
2. Semiconductor Material Synthesis
3. Contract Research and Development (FTE)
4. Customized Services (Including CRO and CMO Services)
5. Antibody-Drug Conjugates (ADC)
The content above was translated by Ai
Founded Year
2023
Unified Business No.
93539342
Status
Active
Number of Employees
0
Total Paid-in Capital
35,150,000 (NT$)
Location of Company
Taiwan , New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups. Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed. Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
About the Company
思微合成生技 possesses professional organic synthesis technology, has completed a series of important projects in the industry, and has a wide scope of services. Our clients include important institutions such as Formosa Laboratories, Handa Biotech, SyneuRx, Panlabs, Foresee Pharmaceuticals, Academia Sinica, the National Chung-Shan Institute of Science and Technology, MacKay Memorial Hospital Laboratory, Chang Gung University, National Taiwan University, National Chiao Tung University Organic Laboratory, and New Applied Materials.

Our R&D team possesses over 10 to 20 years of pharmaceutical GMP experience. In addition to specializing in small-scale (mg) synthesis, we also provide clients with large-scale (kg) process development. We are able to provide professional process optimization services for our clients and assist in introducing products into GMP facilities for GMP-grade scale-up processes. Relying on our unique organic synthesis R&D technology, we are committed to providing our clients with the highest quality services.


The content above was translated by Ai
more ↓

Similar Companies

回頁面最頂端